During the past decade, Specializirana bolnica aktivno lechenie detsa ohcohematologichni zabolyavania Hematologichno conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 1 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Specializirana bolnica aktivno lechenie detsa ohcohematologichni zabolyavania Hematologichno" #1 collaborator was "Millennium Pharmaceuticals, Inc." with 2 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Specializirana bolnica aktivno lechenie detsa ohcohematologichni zabolyavania Hematologichno" are "Disease, Hodgkin" (2 trials), "Lymphoma, Large-Cell, Anaplastic" (1 trials), "Lymphoma, Non-Hodgkin" (1 trials) and "Lymphoma, T-Cell, Cutaneous" (1 trials). Many other conditions were trialed in "Specializirana bolnica aktivno lechenie detsa ohcohematologichni zabolyavania Hematologichno" in a lesser frequency.

Most popular intervention types in "Specializirana bolnica aktivno lechenie detsa ohcohematologichni zabolyavania Hematologichno" are "Drug" (2 trials). Other intervention types were less common.

The name of intervention was led by "brentuximab vedotin" (2 trials) and "placebo" (1 trials). Other intervention names were less common.

The vast majority of trials in "Specializirana bolnica aktivno lechenie detsa ohcohematologichni zabolyavania Hematologichno" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Specializirana bolnica aktivno lechenie detsa ohcohematologichni zabolyavania Hematologichno". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in Specializirana bolnica aktivno lechenie detsa ohcohematologichni zabolyavania Hematologichno, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Specializirana bolnica aktivno lechenie detsa ohcohematologichni zabolyavania Hematologichno, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".